Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Non-Hodgkin's lymphoma. Biologic classification and implication for therapy.

J Kurtzberg1, M L Graham

  • 1Department of Pediatrics, Duke University Medical Center, Durham, North Carolina.

Pediatric Clinics of North America
|April 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Massive clonal expansion of medulloblastoma-specific T cells during adoptive cellular therapy.

Science advances·2019
Same author

Corrigendum.

Journal of investigative surgery : the official journal of the Academy of Surgical Research·2018
Same author

Umbilical cord blood donation: public or private?

Bone marrow transplantation·2015
Same author

Pretreatment of donor pigs with a diet rich in soybean oil increases the yield of isolated islets.

Transplantation proceedings·2014
Same author

Sequential myeloablative autologous stem cell transplantation and reduced intensity allogeneic hematopoietic cell transplantation is safe and feasible in children, adolescents and young adults with poor-risk refractory or recurrent Hodgkin and non-Hodgkin lymphoma.

Leukemia·2014
Same author

In reply.

Transfusion·2014

Significant progress in non-Hodgkin's lymphoma (NHL) research has improved patient outcomes. Ongoing studies focus on refining treatment intensity for early stages and seeking new therapies for advanced disease.

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Background:

  • Non-Hodgkin's lymphomas (NHL) are a diverse group of cancers.
  • Recent decades show significant advancements in understanding NHL biology and treatment efficacy.
  • Associations between lymphomas, viral infections, and immunodeficiency offer insights into neoplasm development.

Purpose of the Study:

  • To summarize the progress in understanding and treating non-Hodgkin's lymphomas.
  • To highlight the impact of recent research on patient prognosis.
  • To outline current treatment strategies and future research directions for NHL.

Main Methods:

  • Review of recent scientific literature on non-Hodgkin's lymphomas.
  • Analysis of trends in NHL tumor biology and treatment effectiveness.

Related Experiment Videos

  • Synthesis of findings related to viral infections and immunodeficiency in lymphoma development.

    • Main Results:

    • Substantial progress in understanding NHL tumor biology and treatment effectiveness over the last decade.
    • Improved prognosis for patients diagnosed with non-Hodgkin's lymphoma.
    • Current research focuses on reducing therapy intensity for favorable stages and seeking novel treatments for advanced disease.

    Conclusions:

    • The prognosis for non-Hodgkin's lymphoma patients continues to improve.
    • Treatment strategies are evolving, with reduced intensity for early-stage disease.
    • Further research is essential to enhance treatment outcomes for patients with advanced non-Hodgkin's lymphoma.